Today

Agents

Chat

Arena

Discover

More

App

Royalty Pharma: JPMorgan raises target price to $74 from $62

RPRX•2026-11-05

JPMorgan raised its target price for Royalty Pharma to $74 from $62.

Related News

G

Gold Fields agrees to buy BHP’s Kambalda Nickel Concentrator

GFI•2026-11-05

Ero Copper Corp.: CIBC cuts target price to C$56 from C$62

ERO•2026-11-05

Guggenheim raises Amgen target price to $435 from $378

AMGN•2026-11-05

Japan bond yields fall as lower oil prices ease inflation concerns

TLT•2026-11-05

Press digest - November 5

RYTM•2026-11-05

Royalty Pharma: JPMorgan raises target price to $74 from $62 - RPRX News | Rallies